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Introduction
The trkB and trkC loci encode a variety of receptor isoforms, in 
addition to the canonical full-length tyrosine kinase receptors 
(Tessarollo, 1998; Huang and Reichardt, 2001). Although sev-
eral kinase-defi  cient Trk receptor isoforms have been identifi  ed 
over the years for both the trkB and the trkC genes, only TrkBT1 
and the truncated TrkC isoform, which we call TrkCT1 in this 
study (also known as TrkCTK [Tsoulfas et al., 1993; Garner and 
Large, 1994; Palko et al., 1999], TrkCNC2 [Menn et al., 1998], 
and TrkCic158 [Valenzuela et al., 1993]), are believed to play 
important roles in vivo. The cytoplasmic tails of these truncated 
receptors are encoded by separate exons, which are evolution-
arily conserved. Their protein products are present in both the 
embryo and in the adult animal, and their expression is dynam-
ically regulated during development (Escandón et al., 1994; 
Menn et al., 1998). To date, the main function attributed to the 
kinase-defi   cient truncated Trk isoforms is inhibition of the 
  kinase-active receptor isoforms, which is achieved by acting as 
a dominant-negative inhibitor of the full-length receptor or by a 
ligand-sequestering mechanism, which limits the neurotrophic 
factor available to bind the kinase-active receptor (Tessarollo, 
1998; Huang and Reichardt, 2001). However, the high degree of 
sequence conservation of the intracellular domains of truncated 
receptors among species suggests the potential for other func-
tions, such as interaction with cytoplasmic adaptor proteins and 
activation of signaling pathways (Baxter et al., 1997; Hapner 
et al., 1998). Indeed, it has recently been reported that brain-
  derived neurotrophic factor induces the production of calcium 
waves in astroglia through the truncated TrkBT1 receptor, and 
that TrkBT1 can alter astrocytic morphology via the regulation 
of Rho GTPase activity (Rose et al., 2003; Ohira et al., 2005). 
To date, no molecules have linked truncated TrkCT1 receptors 
to intracellular signaling pathways. Moreover, there are no data 
on direct biological functions, per se, although it has been re-
ported that TrkCT1 with p75 can induce neural crest cell differ-
entiation, and in animal models of glaucoma truncated TrkCT1 
is overexpressed concomitantly with retinal ganglion cell death 
(Hapner et al., 1998; Rudzinski et al., 2004).
We present the identifi  cation of a new signaling pathway 
activated by the kinase-defi  cient TrkCT1 receptor that employs 
the scaffold protein tamalin (Nevrivy et al., 2000; Kitano et al., 
2002), the cytohesin-2–Arf nucleotide-binding site opener 
(ARNO), the ADP-ribosylation factor 6 (Arf6), and the Rac1 
GTPase. We show that neurotrophin-3 (NT3) activation of this 
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eurotrophins play an essential role in mammalian 
development. Most of their functions have been 
attributed to activation of the kinase-active Trk 
  receptors and the p75 neurotrophin receptor. Truncated 
Trk receptor isoforms lacking the kinase domain are abun-
dantly expressed during development and in the adult; 
however, their function and signaling capacity is largely 
unknown. We show that the neurotrophin-3 (NT3) TrkCT1-
truncated receptor binds to the scaffold protein tamalin in 
a ligand-dependent manner. Moreover, NT3 initiation of 
this complex leads to activation of the Rac1 GTPase through
adenosine diphosphate-ribosylation factor 6 (Arf6). At 
the cellular level, NT3 binding to TrkCT1–tamalin induces 
Arf6 translocation to the membrane, which in turn causes 
membrane rufﬂ  ing and the formation of cellular protru-
sions. Thus, our data identify a new signaling pathway 
elicited by the kinase-deﬁ  cient TrkCT1 receptor. Moreover, 
we   establish NT3 as an upstream regulator of Arf6.
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signaling cascade by TrkCT1 causes Arf6 translocation to the 
membrane, followed by actin reorganization and membrane 
 ruffl  ing. Thus, we have identifi  ed a new pathway that provides 
a mechanism by which NT3 can control cell morphology, shed-
ding light on the elusive role of abundantly expressed truncated 
Trk receptors in development. Moreover, it provides the only 
completely defi  ned growth factor–activated pathway leading to 
Arf activation.
Results
The unique COOH terminus of TrkCT1 is encoded by two 
  exons (13b and 14b in human; Fig. 1 A; Ichaso et al., 1998). 
Exon 14b is the most conserved among species such as mouse, 
human, rat, and chicken. Therefore, we used a yeast two-hybrid 
system to screen an adult mouse brain cDNA library with the 
13-aa-long exon 14b (38 aa) as bait for interacting proteins 
(see Materials and methods). This approach yielded several 
candidate genes, including four independent clones for GRASP/
tamalin (Nevrivy et al., 2000; Kitano et al., 2002). These clones 
initiated at proline 19, alanine 22, arginine 68, and arginine 80. 
Full-length cDNA for tamalin was not isolated.
Next, we analyzed the specifi  city of interaction between   
tamalin and TrkCT1 by assessing yeast two-hybrid β-galactosidase 
activity in liquid assays with a series of COOH- and NH2-termi-
nal deletions of tamalin and exon 13b and/or 14b of TrkCT1. 
All tamalin plasmids isolated from the brain cDNA   library con-
tained an intact Psd-95/Dlg/ZO1 (PDZ) domain, suggesting that 
this domain may be involved in the interaction with TrkCT1. 
Indeed, signifi  cant β-galactosidase activity can only be detected 
when the tamalin PDZ domain is intact (Fig. 1 B). Furthermore, 
the phylogenetically conserved exon 14b of TrkCT1 is both 
necessary and suffi  cient to promote association with the tamalin 
protein. Interestingly, full-length tamalin generates the lowest 
Figure 1.  The tamalin PDZ domain interacts with 
exon 14b of TrkCT1. (A) Schematic representation of 
the full-length TrkC kinase (TrkC-Kin) and truncated 
TrkCT1 receptors. EC, extracellular domain; TM, trans-
membrane domain; JM, juxtamembrane domain. 
(B) Values of β-galactosidase activity obtained by com-
bining different TrkCT1 bait and tamalin prey plasmids 
in liquid assay. Note the high β-galactosidase activity 
when both TrkCT1 exon 14b (aa 575–612) and an 
intact tamalin PDZ domain are used in the assay (box). 
Tamalin plasmid “none” indicates that an empty prey 
plasmid was used. (C) In vitro binding of tamalin to 
TrkCT1 protein fragments, which contain exon 14b. 
GST fusion proteins containing COOH-terminal por-
tions of the TrkCT1 receptor were analyzed for their 
ability to interact in vitro with the full-length tamalin-HA 
protein by GST pull down-assay, as described in 
  Materials and methods. The presence of tamalin was 
detected by immunoblotting with an anti-HA antibody 
(top). Input (bottom) represents 30% of the amount of 
GST–TrkCT1 fusion proteins (arrows) used in the assay 
and visualized by Coomassie staining.TRKCT1 ACTIVATES ARF6–RAC1 SIGNALING • ESTEBAN ET AL. 293
β-galactosidase activity when compared with the other con-
structs that have an intact PDZ domain. Most likely, the full-
length fusion protein does not localize to the nucleus to activate 
reporter expression. This could also explain why no full-length 
tamalin cDNA clones were isolated in the original screen.
To further confi  rm the interaction between tamalin and 
TrkCT1 observed in yeast, we performed in vitro GST pull-
down assays. We tested whether a full-length, COOH-terminal, 
HA-tagged tamalin could bind different GST–TrkCT1 fusion 
proteins (Fig. 1 C). GST alone or GST–TrkCT1 fusion frag-
ments containing the juxtamembrane domain or exon 13b 
failed to pull down tamalin. However, GST fusion proteins 
containing exon 14b were able to interact with tamalin. The de-
letion of even a single aa from the exon 14b COOH terminus 
was suffi  cient to abolish binding to tamalin, suggesting that the 
COOH-terminal tail is responsible for binding to the tamalin 
PDZ-binding domain (unpublished data). These data confi  rmed 
that the interaction between tamalin and TrkC requires an in-
tact exon 14b, which is unique to the TrkCT1 isoform. Further-
more, the results suggest that the juxtamembrane region, which 
is common to both the TrkCT1 and the TrkC kinase–active 
(TrkC-kin) isoforms, is not involved in the interaction. Addi-
tional GST pull-down experiments performed with GST fusion 
proteins, including the kinase domain, also failed to pull down 
tamalin (unpublished data), confi  rming that the interaction be-
tween tamalin and TrkC receptors is specifi  c to the truncated 
TrkCT1 isoform.
To verify that TrkCT1–tamalin interaction is physiologi-
cally possible in the animal, we analyzed their pattern of expres-
sion in the adult mouse brain. In situ hybridization experiments, 
using specifi  c tamalin and TrkCT1 antisense riboprobes, showed 
that this scaffold protein gene and the truncated TrkC receptor 
have an overlapping pattern of expression in several areas of 
the mouse brain. For example, both genes are highly expressed 
in the hippocampus, cortex, striatum, and olfactory bulb (Fig. 2, 
A and B). Furthermore, immunofl  uorescence staining of human 
embryonic kidney 293 (HEK293) cells transfected with TrkCT1 
and tamalin-HA shows that they colocalize at the plasma mem-
brane, indicating that the subcellular localization of these pro-
teins allows their association (Fig. 2, C–E).
Figure 2.  TrkCT1 and tamalin physically in-
teract and colocalize both anatomically and 
subcellularly. (A and B) In situ hybridization 
analysis of sagital sections from an adult mouse 
brain with trkCT1- (A) and tamalin-speciﬁ  c 
(B) antisense riboprobes. Note the overlapping 
pattern of expression in most areas of the fore-
brain, with particularly high levels in the hip-
pocampus. Hi, hippocampus; Cx, cortex; 
St, striatum; OB, olfactory bulb. (C–E) HEK293 
cells transfected with TrkCT1 and tamalin-HA 
were stained with the rabbit anti-TrkC anti-
serum 656 and a mouse monoclonal anti-HA 
  antibody. The secondary antibodies were 
anti–rabbit rhodamine-conjugated (C; TrkCT1) 
or anti–mouse ﬂ  uorescein-conjugated  anti-
bodies (D; HA). Fluorescence imaging demon-
strates the colocalization of both proteins (E) at 
the membrane of the cells, as indicated by the 
yellow color that results from the overlay of red 
and green ﬂ   uorescence. (F) Tamalin and 
TrkCT1 coIP in mammalian cells. HEK293 cells 
transfected with the indicated plasmid and 
treated with NT3 were lysed, immunoprecipi-
tated with a goat anti-TrkC antibody, and 
  immunoblotted with anti-HA and anti-TrkC anti-
body (TrkC 656) as indicated. (top) Western 
blot of a representative experiment is shown. 
(bottom) The amount (input) of TrkCT1 and 
  tamalin in 10% of the total cell lysates used for 
the coIP experiments. (G) Quantiﬁ  cation of im-
munoprecipitated tamalin in double-transfected 
cells from three independent transfections, 
each immunoprecipitated and immunoblotted 
three times (fold difference relative to untreated 
cells). Error bars represent the mean ± SEM, 
relative to untreated cells. *, P < 0.05.JCB • VOLUME 173 • NUMBER 2 • 2006  294
Next, we used coimmunoprecipitation (coIP) experiments 
to investigate if tamalin interacts with TrkCT1 in mammalian 
cells. Lysates obtained from HEK293 cells expressing tamalin-
HA and the truncated TrkCT1 isoform were immunoprecipi-
tated with an anti-TrkC serum and immunoblotted with an 
anti-HA antibody. As shown in Fig. 2 F, the anti-TrkC–specifi  c 
antibody can coIP tamalin-HA only when both tamalin and 
TrkCT1 proteins are present. Therefore, TrkCT1 does interact 
with tamalin in mammalian cells.
To gain insight into the physiological relevance of TrkCT1–
tamalin binding we next investigated whether the TrkC ligand 
NT3 would affect this interaction. TrkCT1 and tamalin were co-
expressed in HEK293 cells. Before lysis, cells were serum 
starved for 4 h, followed by treatment with NT3 for 5 min (Fig. 
2 F). Interestingly, the amount of tamalin-HA associated with 
TrkCT1 was signifi  cantly increased by NT3 (Fig. 2 F). Quantita-
tion from multiple coIP experiments showed that the addition of 
NT3 led to a threefold increase in the amount of tamalin bound 
to TrkCT1 (Fig. 2 G). These data show that the ligand NT3 pro-
motes interaction of TrkCT1 with tamalin and support the physi-
ological relevance of the TrkCT1–tamalin association.
The fi  nding that NT3 promotes the interaction of TrkCT1 
with tamalin in vitro prompted us to expand this observation in 
a physiological context. Mouse hippocampal neurons, which in 
the adult express the highest levels of both tamalin and TrkCT1 
(Fig. 2, A and B), were isolated from embryos, differentiated for 
10–14 d in culture to allow neurons to mature and endogenously 
express truncated TrkCT1 and tamalin, and treated with NT3. 
Confocal microscopy analysis of control neurons stained with 
a specifi  c antibody recognizing the tamalin COOH terminus 
showed that this protein has a diffuse, mainly cytoplasmatic 
  pattern of expression (Fig. 3 A). Conversely, TrkC receptors 
  visualized with a mouse monoclonal antibody recognizing the 
  extracellular region of TrkC appear to be present uniformly 
along the plasma membrane, as previously described (Menn 
et al., 2000), with little or no colocalization with tamalin (Fig. 3 I). 
Interestingly, after NT3 treatment, tamalin distribution becomes 
more punctuate, especially along the neuronal axons, and 
Figure 3.  Tamalin and TrkCT1 colocalize in 
hippocampal neurons in response to NT3. 
  Differentiated control (A, B, E, F, I, and J) and 
TrkC kinase-deﬁ   cient (C, D, G, H, K, and L) 
mouse hippocampal neurons were stained 
with anti-tamalin– (A–D) and anti-TrkC–speciﬁ  c 
(E–H) antibodies and subjected to confocal mi-
croscopy to investigate tamalin (A–D) and TrkC 
cellular distribution in the presence (B, F, J, H, 
D, and L) or absence (A, E, I, C, G, and K) of 
NT3. Analysis of merged rhodamine and FITC 
signals reveals colocalization of tamalin and 
TrkC in response to NT3 treatment (I–L). TrkCT1 
has a speciﬁ   c punctuated pattern of expres-
sion (G and H; Menn et al., 2000) compared 
with a more diffuse distribution of the kinase-
speciﬁ   c TrkC receptor (E and F). Note the 
  particularly strong punctuated overlapping dis-
tribution of tamalin with TrkC in the mutant neu-
rons (D–L, insets) that have only the truncated 
TrkCT1 receptor (arrowheads).TRKCT1 ACTIVATES ARF6–RAC1 SIGNALING • ESTEBAN ET AL. 295
  appears to colocalize with the TrkC receptors. Because this ex-
periment shows that tamalin redistributes in response to NT3 
and colocalizes with TrkC receptors, we repeated this analysis in 
neurons from a TrkC mutant mouse that specifi  cally lacks the 
TrkC kinase isoforms but retains the truncated ones (Klein et al., 
1994; data not depicted). Immunostaining of neurons lacking 
the kinase TrkC isoform reveals a specifi  c punctuated TrkC pat-
tern of expression that is consistent with the previously reported 
pattern of expression of TrkCT1 (Menn et al., 2000). Remark-
ably, neuronal treatment with NT3 shows dotted neuronal redis-
tribution of tamalin that matches the TrkCT1 cellular pattern of 
expression (Fig. 3, d, h, and l, and insets therein). Collectively, 
these data demonstrate that in neurons endogenous tamalin 
  redistributes in response to NT3 and colocalize with TrkCT1.
Tamalin forms a protein complex with cytohesin-2–ARNO 
(Nevrivy et al., 2000; Kitano et al., 2002), which is a member of 
the guanine nucleotide exchange factors for the Arf1 and Arf6 
GTP-binding proteins. ARNOs have been proposed to be part 
of signaling cascades based on the fi  nding that growth factor or 
insulin treatment of cells results in the translocation of ARNOs 
to the cell edge (Langille et al., 1999; Venkateswarlu et al., 1999). 
These results motivated us to examine the effects of NT3 bind-
ing to the TrkCT1–tamalin complex on Arf subcellular localiza-
tion and cell morphology. Because HEK293 cells express 
tamalin (although at a low level; unpublished data), cytohesin 
family exchange factors, and Arfs endogenously (Nevrivy et al., 
2000; Kitano et al., 2002), expression of TrkCT1 should recon-
stitute the NT3-activated pathway. After the generation of a sta-
ble line expressing TrkCT1, we assessed the translocation of 
epitope-tagged Arf6 to actin-rich ruffl  es and protrusions as a 
measure of Arf6 activation in response to NT3 (Radhakrishna 
et al., 1996, 1999; Frank et al., 1998; Franco et al., 1999; Honda 
et al., 1999; Langille et al., 1999; Santy and Casanova, 2001). 
In both the parental HEK293 and TrkCT1 cells, Arf6 associated 
to a small extent with the edge of the cell, as well as with a tubular 
endosomal compartment (Fig. 4, A and G). Treatment of paren-
tal HEK293 cells with NT3 had no signifi  cant effect on the dis-
tribution of Arf6 (Fig. 4, D and Y); in contrast, treatment of the 
HEK293-TrkCT1 cells resulted in the redistribution of Arf6 
from the tubular endosomal compartment to the cell edge in 
 actin-rich  ruffl  es (Fig. 4, J–L [arrows] and Y), whereas Arf1 
had a perinuclear distribution that was not affected by NT3 
(not   depicted). This translocation from the tubular endosomal 
compartment to the cell edge is a well defi  ned consequence of 
Arf6 activation (Radhakrishna et al., 1996; Donaldson, 2003). 
Figure 4.  NT3 binding to TrkCT1 induces Arf6 translocation to the cell 
membrane and rufﬂ  ing. (A–X) HEK293 (A–F) and HEK293 cells stably ex-
pressing TrkCT1 (G–X) were transfected with plasmids directing expression 
of FLAG-Arf6 (A–X), together with plasmids directing expression of wild-
type (M–R) or inactive tamalin (S–X; aa 1–189), and treated with NT3 as 
  indicated (D–F, J–L, P–R, and V–X). Cells were ﬁ  xed, permeabilized, and 
stained for Arf6 (green; A, D, G, J, M, P, and S) and polymerized actin (red; 
B, E, H, and K) or tamalin (red; N, Q, T, and W). Arrows indicate colocaliza-
tion of Arf6 and actin (J–L), and Arf6 and tamalin (P–R) at the cell membrane 
in response to NT3 treatment. Arrowheads in P–R indicate cell protrusions 
caused by NT3 when TrkCT1 and tamalin are coexpressed. (Y) Translocation 
of Arf6 to the membrane of TrkCT1-expressing cells in response to NT3 is in-
hibited by dominant-negative forms of tamalin. Percentage of cells with Arf6 
at the cell edge in either protrusions or rufﬂ  es based on counts of at least 
50 cells in each of two separate experiments. Two separate dominant-negative 
tamalin (aa 99–189 and aa 1–189) were used. Error bars represent the 
mean ± SEM, relative to untreated cells. n ≥ 100. **, P < 0.01; ***, 
P < 0.001. ANOVA followed by a Tukey test were used for both. Bars, 5 μm.JCB • VOLUME 173 • NUMBER 2 • 2006  296
  Moreover, tamalin was necessary for Arf6 activation through 
TrkCT1 because transfection of two independent dominant-
negative forms containing the PDZ domain of tamalin blocked 
these effects (Fig. 4, S–Y). In contrast, the response of TrkCT1 
cells overexpressing tamalin to NT3 was more robust than that 
of the nontransfected cells, with Arf6 moving from a tubular 
endosomal compartment (Fig. 4 M) to the cell edge in ruffl  es 
(Fig. 4, P–R [arrows] and Y) and large protrusions (Fig. 4, P–R, 
arrowheads) colocalizing with tamalin.
Because we could not exclude that dominant-negative 
  tamalin might block NT3 signaling by masking the TrkCT1 
docking site encoded by exon 14b, we next investigated whether 
a catalytically inactive form of cythohesin-2–ARNO would 
  affect NT3-mediated ruffl   ing (Fig. 5). E156K-ARNO has a 
  mutation in the Sec7 domain that blocks the ability of ARNO to 
promote GTP exchange at Arf6 but does not disrupt its ability 
to bind to other proteins (Frank et al., 1998). Transfection of 
E156K-ARNO into HEK293-TrkCT1 cells blocked actin poly-
merization (Fig. 5, J–L), whereas wild-type ARNO enhanced 
NT3-mediated actin polymerization at the cell edge (Fig. 5, D–F). 
Thus, these data strongly suggest that NT3 mediates ruffl  ing 
through the TrkCT1–tamalin–cythohesin-2–ARNO pathway.
Arfs function as GDP/GTP-regulated switches in the 
pathways that stimulate actin reorganization and membrane 
 ruffl  ing (Randazzo et al., 2000). Part of this effect is mediated 
by Rac1, which is a well characterized Rho GTPase located 
Figure 5.  Cytohesin-2–ARNO mediates NT3-induced membrane 
rufﬂ  ing and actin protrusion formation. HEK293 cells expressing 
TrkCT1 were transfected with a wild-type HA-tagged (WT-ARNO; 
A–F) or a catalytically inactive Myc-tagged ARNO (E156K-
ARNO; G–L) and stained for polymerized actin. Rufﬂ  ing, as indi-
cated by the extensive presence of polymerized actin, is seen in 
cells expressing WT-ARNO in response to NT3 (D–F and arrows 
in E). On the contrary, the catalytically inactive E156-ARNO dis-
rupts actin polymerization in response to NT3 (K), although it 
gets recruited to the cell edge because it can still bind tamalin 
(J, arrows). Arrowheads in K indicate rufﬂ  ing in cells that do not 
express the inactive E156-ARNO, but are still able to use the 
  endogenous ARNO for NT3 signaling. (M) Percentage of cells 
with actin at the cell edge in response to NT3 was determined 
from untransfected (TrkC.T1) or transfected (TrkC.T1-WT ARNO 
and TrkC.T1–E156K-ARNO) cells from two separate experiments. 
Error bars represent the mean ± SEM. Bars, 10 μm.TRKCT1 ACTIVATES ARF6–RAC1 SIGNALING • ESTEBAN ET AL. 297
  downstream of Arf6 (Radhakrishna et al., 1999; Santy and 
  Casanova, 2001). Therefore, we investigated whether NT3 
  signaling trough TrkCT1–tamalin leads to Rac1 activation 
(Radhakrishna et al., 1996; Santy and Casanova, 2001). We 
found that NT3 treatment of HEK293 cells transfected with 
TrkCT1 and tamalin caused a 4.1 ± 0.47–fold increase in Rac1 
activity (Fig. 6, A and B, compare lanes 5 and 6). Moreover, 
only expression of a dominant-negative form of Arf6 could 
block Rac1 activation, whereas expression of inactive Arf1 had 
no effect on Rac1 activation (Fig. 6, A and B, lanes 7 and 8). 
These data demonstrate that NT3 signaling through TrkCT1–
  tamalin can modulate Rac1 through Arf6 activation.
Discussion
In this study, we describe the identifi  cation of a new signaling 
pathway activated by an evolutionarily conserved truncated iso-
form of the TrkC receptor. This pathway links NT3 to down-
stream molecules affecting the regulation of actin cytoskeleton 
and membrane traffi  cking through TrkCT1 and the scaffold 
  protein tamalin (Fig. 7). 
The interaction of TrkCT1 with tamalin suggests a novel 
mechanism by which neurotrophins affect the development, 
maintenance, and function of the mammalian nervous system. 
Tamalin forms a protein complex with multiple postsynaptic 
and protein-traffi  cking scaffold proteins, suggesting that NT3 
could be an extracellular trigger of these cellular processes by 
causing the recruitment of tamalin to TrkCT1 (Kitano et al., 
2003). Among the several postsynaptic proteins with which 
  tamalin interacts are the group 1 metabotropic glutamate recep-
tors (mGluR1 and mGluR5) that affect ion channels and intra-
cellular second messengers through G proteins (Schoepp et al., 
1990; Aramori and Nakanishi, 1992). Glutamate receptors play 
a key role in neural development, especially in neuronal plastic-
ity (Nakanishi and Masu, 1994; Nicoletti et al., 1999). It has 
been suggested that these mGluR1 functions may be mediated 
by tamalin, which provides a direct link to cytohesin-2–Arf 
GTP-binding proteins, which are involved in membrane traf-
fi  cking, cytoskeletal reorganization, and phospholipase D acti-
vation (Nevrivy et al., 2000; Kitano et al., 2002). Thus, it is 
possible that the interaction of tamalin with TrkCT1 may 
  provide a molecular pathway similar to the one activated by 
mGluR1 and by which neurotrophins can affect neuronal plas-
ticity in mammals, a function that is still not well understood.
Several lines of evidence suggest that characteristic axonal 
and dendritic morphologies throughout the nervous system are 
determined, in part, by local patterns of expression of neuro-
trophins and neurotrophin receptors (Snider, 1988; Cohen-Cory 
and Fraser, 1995; McAllister et al., 1996, 1997; Lentz et al., 
1999). For example, transfection of explant cultures of dorsal root 
ganglia neurons with the TrkC kinase or the TrkCT1 receptor re-
vealed that specifi  c ratios of receptor isoforms are associated with 
different axonal morphologies. Specifi  cally, neurons overexpress-
ing tyrosine kinase containing TrkC showed enhanced elabora-
tion of major axonal processes, whereas the truncated isoform 
reduced elaboration of major processes and increased branching 
(Ichinose and Snider, 2000). Our data suggest that the effect on 
truncated TrkCT1 by NT3 may affect neuronal morphology, 
not by affecting the TrkC full-length receptor by a dominant-
negative mechanism, but, rather, by activating Arfs and Rac1 
GTPases that are known modulators of cell morphology.
In summary, this newly discovered neurotrophin-activated 
pathway may provide a means by which NT3 can exert some of 
its critical functions in development and might explain why 
mice lacking all TrkC receptor isoforms, including the TrkCT1, 
display a more severe phenotype than mice lacking the full-
length TrkC tyrosine kinase receptors exclusively (Tessarollo 
et al., 1997). Importantly, these results identify a novel signal-
ing pathway upstream of Arf6 in which an activated receptor 
binds directly to an ARNO-binding protein to stimulate ARNO 
and consequent nucleotide exchange on Arf6.
Materials and methods
Yeast two-hybrid screening
The PCR-ampliﬁ   ed COOH-terminal region of the TrkCT1 isoform (corre-
sponding to residues 575–612 of the rat TrkCT1 [Tsoulfas et al., 1993] or 
exon 14b of the human TrkC-truncated receptor [Ichaso et al., 1998]) was 
subcloned in frame to the GAL4-binding domain of the bait plasmid pGBD.C2. 
Figure 6.  NT3 induces Rac1 activation via the TrkCT1–tamalin–Arf6 
  pathway. (A) HEK293 cells expressing TrkCT1 (lane 3), tamalin-HA (lane 2), 
and TrkCT1 and tamalin-HA (lanes 5–8) in the absence (lanes 5 and 6) or 
presence of inactive Arf1 (lane 7) or Arf6 (lane 8) were serum starved for 
13 h and stimulated with 100 ng/ml of NT3 for 5 min, where indicated. 
Relative Rac1 activity to total Rac1 protein normalized to the basal activity 
present in untransfected HEK293 cells is shown. Input for Rac1, tamalin, 
TrkCT1, and Arf1T31N or Arf6T27N represents 1% of the total cell extract 
used to detect the active Rac1-GTP (top). (B) Quantiﬁ  cation of Rac1 activa-
tion in response to NT3 treatment. The fold difference is mean ± SEM, rela-
tive to untreated cells (lane 1). Error bars represent the mean ± SEM from 
six independent experiments, except for the experiments performed with 
the Arf1 or Arf6 dominant-negative forms (three experiments).JCB • VOLUME 173 • NUMBER 2 • 2006  298
This fusion bait plasmid and an adult mouse brain cDNA library fused in 
frame to the GAL4 activation domain (Mouse Brain MATCHMAKER cDNA 
Library; CLONTECH Laboratories, Inc.) were sequentially transformed into 
the yeast strain PJ69-4A and subjected to colony selection and liquid 
β-galactosidase assays. Different tamalin deletion prey and TrkCT1 bait 
plasmids were generated by cloning PCR-generated cDNA fragments into 
pACT2 (CLONTECH Laboratories, Inc.) and pGBD.C2, respectively, and 
were used for subsequent two-hybrid analysis.
Cell culture
HEK293 cells were grown in DME (Invitrogen) supplemented with 10% 
FBS, 100 U/ml of penicillin/streptomycin at 37°C, and 5% CO2. Cells 
were transfected using Fugene 6 (Roche) or Lipofectamine 2000 reagent 
(Invitrogen) according to the manufacturer’s protocol. Mouse embryonic 
hippocampus neurons were dissected from 18-d-old mouse embryos by the 
standard technique and seeded on coverslips pretreated with poly-D-lysine, 
collagen, and laminin. Cells were grown for 2 wk on DME supplemented 
with 2% B27, 5% fetal calf serum, 100 U/ml of penicillin/streptomycin, 
and 4 μM AraC; the media was changed every 3–4 d.
GST pull-down assay
GST–TrkC fusion proteins were generated by cloning the appropriate PCR 
products containing different rat TrkCT1 or TrkC full-length regions (Tsoulfas 
et al., 1993) in pGEX-4T-1 (GE Healthcare). The expression of the GST fusion 
proteins in Escherichia Coli strain BL21 was induced with IPTG, and soluble 
cell extracts were generated by sonication in lysis buffer containing PBS, 
pH 7.4, 1 mM EDTA, 1% Triton X-100 and complete mini EDTA-free protease 
inhibitor (Roche). The soluble proteins were immobilized on glutathione–
  Sepharose CL-4B beads (GE Healthcare) for 1 h at RT, washed ﬁ  ve times with 
lysis buffer (PBS, pH 7.4, 1 mM EDTA, 1% NP-40, and complete mini EDTA-
free protease inhibitor), and incubated with HEK293 cell extracts expressing 
the full-length COOH-terminal HA-tagged tamalin (tamalin-HA) protein in 
500 μl of lysis buffer for 10–12 h at 4°C. The beads were washed ﬁ  ve times 
with lysis buffer on a MicroSpin column (GE Healthcare). The bound proteins 
were eluted by centrifugation after heating at 95°C for 3 min in 2× SDS-
PAGE loading buffer, separated by SDS-PAGE on 4–12% acrylamide gels 
(Invitrogen), and immunoblotted for detection with an anti-HA mouse mono-
clonal peroxidase-conjugated   antibody (High Afﬁ  nity 3F10; Roche).
coIP
A HEK293 line expressing TrkCT1 (HEK293-TrkCT1) was generated by 
transfection with a pcDNA3.1 puromycin-resistant plasmid containing the 
TrkCT1 cDNA. For protein expression experiments, a tamalin-HA plasmid 
was transiently transfected into naive HEK293 cells or the HEK293-TrkCT1 
line, and lysates were prepared for protein analysis. A goat anti-TrkC 
(Upstate Biotechnology) antibody was used for coIP experiments. Immuno-
precipitates were resolved by SDS-PAGE (4–12% gel) and immunodetected 
with the anti-HA antibody and the rabbit anti–TrkC 656 antiserum (raised 
against aa 484–501 of the juxtamembrane region; a gift from P. Tsoulfas, 
University of Miami, Miami, FL). Rac1 activation was measured using a 
nonradioactive Rac activation assay kit (CHEMICON International, Inc.) 
following the manufacturer’s recommendations.
In situ hybridization and immunocytochemistry
In situ hybridization protocols using the antisense full-length tamalin (Kitano 
et al., 2002) or the TrkCT1-speciﬁ  c sequence (corresponding to exon 13b and 
14b and the subsequent 286 bases of the 3′ un-translated region) riboprobes 
were performed as previously described (Tessarollo and Parada, 1995).
For immunocytochemical experiments, cells were transfected with 
the pcDNA3.1 (+) expression vector, containing the open reading frame 
for FLAG-tagged wild-type human Arf6 and ARNO (wild-type ARNO), 
Myc-tagged wild-type tamalin and mutant E156K-ARNO, and HA-tagged 
mutant (aa 1–189) tamalin. 10 μg of wild-type human Arf6 or 7 μg of 
wild-type ARNO and E156K-ARNO were used in single transfection; 5 μg 
of wild-type human Arf6 and 8 μg of wild-type or mutant tamalin were 
used in cotransfection experiments. Transfected cells were plated on 
100-mm culture dishes precoated with poly-D-lysine (20 μg/ml for 10 min 
at 25°C). 24 h later, they were reseeded on ﬁ  bronectin-coated coverslips 
in serum-free medium (OPTI-MEM; Invitrogen) and incubated for 12 h at 
37°C. To determine their responses to NT3, cells or primary neurons were 
starved for 4 h and incubated with 100 ng/ml NT3 (Upstate Biotechnology) 
for 5 min at RT before ﬁ  xation. HEK293 cells were ﬁ  xed in 2% paraformal-
dehyde in PBS for 10 min at RT, washed three times with PBS and once in 
PBS containing 10% FBS and 0.04% sodium azide, and permeabilized 
with staining buffer (PBS containing 10% FBS, 0.2% saponin, and 0.04% 
sodium azide) for 10 min at RT. Mouse hippocampal neurons were ﬁ  xed 
for 30 min in 4% paraformaldehyde, washed three times in PBS, and 
blocked overnight with mouse IgG blocking reagent (Vector Laboratories) 
in PBS. After two washes in PBS, they were incubated for 30 min in 0.1% 
Triton X-100, 5% mouse protein concentrate (Vector Laboratories), and 5% 
normal goat serum (S1000; Sigma-Aldrich) in PBS. After incubation with 
the primary antibodies in staining buffer for 1–3 h at RT, cells were washed 
three times for 10 min with staining buffer and incubated with FITC- or 
  rhodamine-conjugated secondary antibodies (Jackson ImmunoResearch 
Laboratories) for 1 h at RT. After three 10-min washes, glass coverslips 
were mounted on slides with ﬂ  uorescent mounting medium (Dakocytomation). 
Cells were visualized at RT by confocal microscopy with a confocal system 
(LSM510 NLO) and with an inverted microscope (Axiovert 200M; both 
Carl Zeiss MicroImaging, Inc.) and operating with a 25-mW argon laser 
tuned to 488 nm and a 1-mW HeNe laser tuned to 543 nm. Cells were 
  imaged with a 63×, 1.4 NA, oil immersion objective for HEK293 cells and 
Plan-Neoﬂ  uar 40×, 1.3 NA, oil differential interference contrast objective 
for neuron analysis. Using AIM software (Carl Zeiss MicroImaging, Inc.), 
images were collected using a multitrack conﬁ  guration where the FITC and 
rhodamine signals were sequentially collected with a bp 500–550-nm ﬁ  lter 
and a bp 565–615-nm ﬁ  lter after sequential excitation with the 488- and 
Figure 7.  Schematic representation of the 
newly identiﬁ   ed NT3-activated signaling 
  pathway. NT3 binding to TrkCT1 causes the 
recruitment of tamalin to the TrkCT1 cytoplasmic 
domain (exon 14b). In turn, tamalin activates 
the guanine nucleotide exchange factors 
  cytohesin-2–ARNO (Kitano et al., 2002), which 
causes the switch of Arf6 from its inactive to its 
active Arf6-GTP form. Arf6-GTP induces Rac1 
activation and is translocated to the mem-
brane, where rufﬂ  ing and actin reorganization 
take place. Tamalin alanine/proline (A/P), 
PDZ, leucine rich (Leu), and PDZ-binding (SQL) 
domains are indicated, as well as ARNO’s 
pleckstrin homology (PH), coiled coil, and 
Sec7 homology domains.TRKCT1 ACTIVATES ARF6–RAC1 SIGNALING • ESTEBAN ET AL. 299
543-nm laser lines, respectively. Antibodies were used at the following 
concentration in PBS: polyclonal anti-TrkC 656 (1:100), polyclonal anti-HA 
(1:5,000; Roche), monoclonal M5 anti-FLAG (1:1,000; Sigma-Aldrich), 
polyclonal anti-Myc (1:100; Santa Cruz Biotechnology, Inc.), polyclonal 
rabbit anti-tamalin (1:1,500, against the T  E  A  R  E  Q  A  L  C  G  A  G  L  R  K  T  K  Y  R  S  F  R   
epitope of the mouse tamalin COOH terminus), and mouse monoclonal 
TrkC 2B7 (1:1,500, raised against epitope E  S  T  D  N  F  I  L  F  D  E  V  S  P  T  P  P  I   of the 
human TrkC extracellular domain).
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